Disc Medicine Q3 EPS $(0.58) Beats $(0.80) Estimate
Portfolio Pulse from Benzinga Newsdesk
Disc Medicine (NASDAQ:IRON) reported Q3 losses of $(0.58) per share, beating the analyst consensus estimate of $(0.80) by 27.5 percent.
November 09, 2023 | 1:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Disc Medicine's Q3 EPS of $(0.58) beat the analyst consensus estimate by 27.5%, which could positively impact the stock in the short term.
Earnings per share (EPS) is a key indicator of a company's profitability. When a company's EPS beats estimates, it often leads to a positive reaction in the stock market. In this case, Disc Medicine's EPS beat the consensus estimate by a significant margin (27.5%), which could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100